A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...

A pair of studies show that Zepbound can help adults with obesity and overweight achieve sustained and meaningful weight loss ...

Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.

By December 2023, 12.3% of all glucose-lowering medication dispensations were tirzepatide among adults with T2DM.

For patients with inadequately controlled T2D receiving dulaglutide, switching to tirzepatide is associated with additional HbA1c reduction and weight loss.

Switching to tirzepatide associated with hemoglobin A1c reduction and weight loss compared with escalating treatment with dulaglutide.

Patients with poorly controlled type 2 diabetes despite being on dulaglutide had better outcomes if they switched to tirzepatide than if they upped their dulaglutide dose. In this randomized trial ...

MG refreshed its hybrid lineup last year, and so now it’s the turn of the electric crop – meet the all new MGS5 EV. Never underestimate the power of a cut space, as Ingolstadt’s lawyers are ...

You’re looking at the new MG S5 EV, yet another new challenger in the increasingly busy B-segment SUV market and the fifth EV from the brand. It’ll ride on the same Modular Scalable Platform ...

Primary endpoint met in the 8-week treatment study (highly statistically significant). Co-administered group had a 4.4% reduction in weight compared to 1.6% for the placebo group (p<0.0001).

Primary analysis for the co-administered group in the 8-week treatment study showed: 40% of patients achieved 5% ... Low dose bremelanotide arm stopped weight regain seen post tirzepatide treatment.

Join 1000s of buyers using the power of Australia's leading new car destination to save time, money and stress. Find a deal The MG 5 is Australia’s cheapest sedan – that’s one way of looking at it.